Do analysts rate BOXL or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boxlight 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor BOXL or TNFA?

In the previous week, Boxlight had 4 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 5 mentions for Boxlight and 1 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.54 beat Boxlight's score of -0.24 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boxlight 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TNF Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend TNFA or AGMH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AGM Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, TNFA or AGMH?

AGM Group has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A AGM Group $30.56M 0.08 $560K N/A N/A

Is TNFA or AGMH more profitable?

AGM Group's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets TNF Pharmaceuticals N/A -69.21% -33.98% AGM Group N/A N/A N/A

Does the media refer more to TNFA or AGMH?

In the previous week, AGM Group had 3 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 4 mentions for AGM Group and 1 mentions for TNF Pharmaceuticals. AGM Group's average media sentiment score of 0.59 beat TNF Pharmaceuticals' score of 0.54 indicating that AGM Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TNF Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AGM Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate AIMDW or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, AIMDW or TNFA?

Ainos has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $13.60K N/A N/A N/A N/A TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A

Is AIMDW or TNFA more profitable?

Ainos' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Ainos N/A N/A N/A TNF Pharmaceuticals N/A -69.21% -33.98%

Do analysts recommend TNFA or CCCXW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Churchill Capital Corp X/Cayman 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, TNFA or CCCXW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A Churchill Capital Corp X/Cayman N/A N/A N/A N/A N/A

Is TNFA or CCCXW more profitable?

Churchill Capital Corp X/Cayman's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets TNF Pharmaceuticals N/A -69.21% -33.98% Churchill Capital Corp X/Cayman N/A N/A N/A

Do analysts rate WLDS or TNFA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wearable Devices 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TNF Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, WLDS or TNFA?

Wearable Devices has higher revenue and earnings than TNF Pharmaceuticals. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wearable Devices $650K 2.69 -$8.11M N/A N/A TNF Pharmaceuticals N/A N/A -$23.36M -$231.00 N/A

Is WLDS or TNFA more profitable?

Wearable Devices' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Wearable Devices N/A N/A N/A TNF Pharmaceuticals N/A -69.21% -33.98%

Does the media prefer WLDS or TNFA?

In the previous week, Wearable Devices had 5 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 6 mentions for Wearable Devices and 1 mentions for TNF Pharmaceuticals. Wearable Devices' average media sentiment score of 0.86 beat TNF Pharmaceuticals' score of 0.54 indicating that Wearable Devices is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wearable Devices 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TNF Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

TNF Pharmaceuticals (TNFA) Competitors

$1.02 +0.14 (+15.99%)

As of 09/24/2026

Compare

TNFA vs. BOXL, AGMH, AIMDW, CCCXW, and WLDS

Should you buy TNF Pharmaceuticals stock or one of its competitors? TNF Pharmaceuticals's main competitors and comparable companies include Boxlight (BOXL), AGM Group (AGMH), Ainos (AIMDW), Churchill Capital Corp X/Cayman (CCCXW), and Wearable Devices (WLDS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "technology hardware, storage & peripherals" industry.

How does TNF Pharmaceuticals compare to Boxlight?

Boxlight (NASDAQ:BOXL) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boxlight	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Boxlight has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market. Comparatively, TNF Pharmaceuticals has a beta of 2.04, indicating that its stock price is 104% more volatile than the broader market.

TNF Pharmaceuticals has a net margin of 0.00% compared to Boxlight's net margin of -20.96%. Boxlight's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boxlight	-20.96%	N/A	-23.50%
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

TNF Pharmaceuticals has lower revenue, but higher earnings than Boxlight. Boxlight is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boxlight	$109.25M	0.03	-$23.81M	-$80.86	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

In the previous week, Boxlight had 4 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 5 mentions for Boxlight and 1 mentions for TNF Pharmaceuticals. TNF Pharmaceuticals' average media sentiment score of 0.54 beat Boxlight's score of -0.24 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boxlight	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TNF Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

6.5% of Boxlight shares are owned by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 15.4% of Boxlight shares are owned by company insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Boxlight and TNF Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to AGM Group?

TNF Pharmaceuticals (NASDAQ:TNFA) and AGM Group (NASDAQ:AGMH) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

TNF Pharmaceuticals has a beta of 2.04, suggesting that its share price is 104% more volatile than the broader market. Comparatively, AGM Group has a beta of 2.52, suggesting that its share price is 152% more volatile than the broader market.

AGM Group's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
AGM Group	N/A	N/A	N/A

In the previous week, AGM Group had 3 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 4 mentions for AGM Group and 1 mentions for TNF Pharmaceuticals. AGM Group's average media sentiment score of 0.59 beat TNF Pharmaceuticals' score of 0.54 indicating that AGM Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TNF Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AGM Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AGM Group has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
AGM Group	$30.56M	0.08	$560K	N/A	N/A

9.6% of TNF Pharmaceuticals shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by company insiders. Comparatively, 34.9% of AGM Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AGM Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

AGM Group beats TNF Pharmaceuticals on 8 of the 9 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Ainos?

Ainos (NASDAQ:AIMDW) and TNF Pharmaceuticals (NASDAQ:TNFA) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

9.6% of TNF Pharmaceuticals shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ainos' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

Ainos has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$13.60K	N/A	N/A	N/A	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

In the previous week, Ainos had 1 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 2 mentions for Ainos and 1 mentions for TNF Pharmaceuticals. Ainos' average media sentiment score of 1.39 beat TNF Pharmaceuticals' score of 0.54 indicating that Ainos is being referred to more favorably in the media.

Company	Overall Sentiment
Ainos	Positive
TNF Pharmaceuticals	Positive

Summary

Ainos beats TNF Pharmaceuticals on 5 of the 8 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Churchill Capital Corp X/Cayman?

TNF Pharmaceuticals (NASDAQ:TNFA) and Churchill Capital Corp X/Cayman (NASDAQ:CCCXW) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 0.5% of TNF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A
Churchill Capital Corp X/Cayman	N/A	N/A	N/A	N/A	N/A

Churchill Capital Corp X/Cayman's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TNF Pharmaceuticals	N/A	-69.21%	-33.98%
Churchill Capital Corp X/Cayman	N/A	N/A	N/A

In the previous week, TNF Pharmaceuticals had 1 more articles in the media than Churchill Capital Corp X/Cayman. MarketBeat recorded 1 mentions for TNF Pharmaceuticals and 0 mentions for Churchill Capital Corp X/Cayman. TNF Pharmaceuticals' average media sentiment score of 0.54 beat Churchill Capital Corp X/Cayman's score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
TNF Pharmaceuticals	Positive
Churchill Capital Corp X/Cayman	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Churchill Capital Corp X/Cayman	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

TNF Pharmaceuticals beats Churchill Capital Corp X/Cayman on 5 of the 7 factors compared between the two stocks.

How does TNF Pharmaceuticals compare to Wearable Devices?

Wearable Devices (NASDAQ:WLDS) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Wearable Devices has higher revenue and earnings than TNF Pharmaceuticals.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wearable Devices	$650K	2.69	-$8.11M	N/A	N/A
TNF Pharmaceuticals	N/A	N/A	-$23.36M	-$231.00	N/A

Wearable Devices' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wearable Devices	N/A	N/A	N/A
TNF Pharmaceuticals	N/A	-69.21%	-33.98%

In the previous week, Wearable Devices had 5 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 6 mentions for Wearable Devices and 1 mentions for TNF Pharmaceuticals. Wearable Devices' average media sentiment score of 0.86 beat TNF Pharmaceuticals' score of 0.54 indicating that Wearable Devices is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wearable Devices	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TNF Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wearable Devices	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TNF Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

0.2% of Wearable Devices shares are owned by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 0.5% of TNF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Wearable Devices beats TNF Pharmaceuticals on 6 of the 8 factors compared between the two stocks.

Get TNF Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TNFA vs. The Competition

Export

Metric	TNF Pharmaceuticals	Technology Hardware, Storage & Peripherals Industry	Technology Sector	NASDAQ Exchange
Market Cap	$1.88M	$118.58B	$31.09B	$13.16B
Dividend Yield	N/A	1.64%	2.74%	12.57%
P/E Ratio	0.00	30.47	79.13	25.77
Price / Sales	N/A	92.61	591.00	111.13
Price / Cash	N/A	22.09	49.70	52.76
Price / Book	0.00	8.37	7.93	6.30
Net Income	-$23.36M	$3.49B	$702.31M	$359.77M
7 Day Performance	34.21%	2.01%	1.09%	-0.18%
1 Month Performance	-57.68%	-2.85%	-1.92%	-4.08%
1 Year Performance	-77.35%	66.78%	178.73%	6.08%

TNF Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TNFA TNF Pharmaceuticals	0.1206 of 5 stars	$1.02 +16.0%	N/A	-83.1%	$1.88M	N/A	N/A	6
BOXL Boxlight	0.3168 of 5 stars	$5.08 -6.4%	N/A	-95.5%	$3.62M	$109.25M	N/A	180	Short Interest Increase
AGMH AGM Group	0.3928 of 5 stars	$0.76 -7.8%	$5.77 +662.2%	-90.3%	$2.65M	$30.56M	N/A	20	News Coverage Short Interest Increase Gap Up
AIMDW Ainos	N/A	$0.11 +36.1%	N/A	-33.3%	$0.00	$13.60K	N/A	40	Short Interest Decrease Gap Down
CCCXW Churchill Capital Corp X/Cayman	N/A	$6.37 flat	N/A	N/A	$0.00	N/A	N/A	2

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TNFA) was last updated on 9/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TNF Pharmaceuticals (TNFA) Competitors

TNFA vs. BOXL, AGMH, AIMDW, CCCXW, and WLDS

How does TNF Pharmaceuticals compare to Boxlight?

Summary

How does TNF Pharmaceuticals compare to AGM Group?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Summary

How does TNF Pharmaceuticals compare to Churchill Capital Corp X/Cayman?

Summary

How does TNF Pharmaceuticals compare to Wearable Devices?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNFA vs. The Competition

TNF Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TNF Pharmaceuticals (TNFA) Competitors

TNFA vs. BOXL, AGMH, AIMDW, CCCXW, and WLDS

How does TNF Pharmaceuticals compare to Boxlight?

Do analysts rate BOXL or TNFA?

Which has more volatility and risk, BOXL or TNFA?

Is BOXL or TNFA more profitable?

Which has better valuation and earnings, BOXL or TNFA?

Does the media favor BOXL or TNFA?

Do insiders and institutionals hold more shares of BOXL or TNFA?

Summary

How does TNF Pharmaceuticals compare to AGM Group?

Which has more risk and volatility, TNFA or AGMH?

Is TNFA or AGMH more profitable?

Does the media refer more to TNFA or AGMH?

Which has preferable valuation and earnings, TNFA or AGMH?

Do institutionals & insiders believe in TNFA or AGMH?

Do analysts recommend TNFA or AGMH?

Summary

How does TNF Pharmaceuticals compare to Ainos?

Do insiders & institutionals believe in AIMDW or TNFA?

Do analysts rate AIMDW or TNFA?

Is AIMDW or TNFA more profitable?

Which has preferable earnings and valuation, AIMDW or TNFA?

Does the media favor AIMDW or TNFA?

Summary

How does TNF Pharmaceuticals compare to Churchill Capital Corp X/Cayman?

Do insiders and institutionals believe in TNFA or CCCXW?

Which has better valuation & earnings, TNFA or CCCXW?

Is TNFA or CCCXW more profitable?

Does the media favor TNFA or CCCXW?

Do analysts recommend TNFA or CCCXW?

Summary

How does TNF Pharmaceuticals compare to Wearable Devices?

Which has preferable valuation & earnings, WLDS or TNFA?

Is WLDS or TNFA more profitable?

Does the media prefer WLDS or TNFA?

Do analysts rate WLDS or TNFA?

Do institutionals & insiders have more ownership in WLDS or TNFA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TNFA vs. The Competition

TNF Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools